Novel Drug Delivery Systems Market By Route of Administration (Oral Drug Delivery Systems, Injectable Drug Delivery Systems, Pulmonary Drug Delivery Systems, Transdermal Drug Delivery Systems, and Other Routes of Administration), By Mode of NDDS (Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, and Modulated Drug Delivery Systems), and By Region - Trends, Analysis and Forecast till 2030

Report Code: PMI153519 | Publish Date: July 2023 | No. of Pages: 168

Global Novel Drug Delivery Market Companies

  • Abbott Laboratories
  • AstraZeneca PLC
  • Bayer AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi SA.

Recent News:

  • In June 2022, Esteve Pharmaceuticals GmbH launches INBRIJA 33 mg (levodopa inhalation powder,  capsules) in Germany. INBRIJA is indicated in the EU for the intermittent treatment of episodic motor fluctuations in adult patients with Parkinson's disease treated with levodopa/dopa decarboxylase inhibitors.
  • In June 2022, EVERSANA and Accord BioPharma have partnered to support the recent launch of CAMCEVI (leuprolide) injectable emulsion 42 mg for the treatment of advanced prostate cancer in adults.